Psychiatry · Atlanta, GA
NPI
1881603553
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
The Center for Health and Rehabilitation, 265 Boulevard NE
Atlanta, GA, 30312
Phone (404) 665-8600
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.9M
3,514 prescriptions
Company payments, 2025
$1,047
From 11 companies
Medicare prescription drug claims, 2024
In 2024, the drug William E Whissell prescribed most often to Medicare patients was Benztropine Mesylate, with 255 prescriptions and refills. In total William E Whissell wrote 3,514 Medicare prescriptions that cost $1.9M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-09-16.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Benztropine Mesylate Generic | 255 | 362 | 46 | $2,575 |
| Olanzapine Generic | 241 | 355 | 37 | $9,793 |
| Risperidone Generic | 239 | 356 | 44 | $3,018 |
| Fluoxetine Hcl Generic | 205 | 310 | 40 | $992 |
| Invega Sustenna Paliperidone Palmitate | 194 | 194 | 20 | $582K |
| Divalproex Sodium Er Divalproex Sodium | 166 | 219 | 26 | $6,511 |
| Aripiprazole Generic | 163 | 244 | 35 | $13K |
| Quetiapine Fumarate Generic | 149 | 236 | 33 | $3,102 |
| Trazodone Hcl Generic | 145 | 242 | 38 | $804 |
| Sertraline Hcl Generic | 129 | 228 | 30 | $668 |
| Ziprasidone Hcl Generic | 122 | 208 | 22 | $11K |
| Invega Trinza Paliperidone Palmitate | 109 | 325 | 28 | $833K |
| Haloperidol Generic | 107 | 119 | 15 | $1,928 |
| Bupropion Xl Bupropion Hcl | 93 | 171 | 21 | $2,049 |
| Duloxetine Hcl Generic | 86 | 126 | 15 | $1,040 |
Brand drugs: - claims; generic drugs: 3,081 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William E Whissell $1,047 ($1,047 in general payments such as food, travel and fees) from 11 companies. The largest payer was Alkermes, Inc. with $197.
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. ALKS | 10 | $197 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 9 | $155 |
| Teva Pharmaceuticals USA, Inc. TEVA | 15 | $138 |
| Neurocrine BioSciences, Inc. NBIX | 4 | $108 |
| Janssen Pharmaceuticals, Inc JNJ | 5 | $92.19 |
| Luye Pharma (USA) Ltd. 2186.HK | 3 | $82.7 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $80.63 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $75.29 |
| Abbvie Inc. ABBV | 3 | $53.62 |
| Lundbeck LLC | 2 | $46.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.